Rifampicin-induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report
Moussa C, Esbaa S, Rouis H, Sellami N, Hajji M, Houcine Y, Khattab A, Khouaja I, et al. (10 authors)
Respirology case reports · 2023-07
Abstract
Drug-induced tubulointerstitial nephritis is an uncommon complication in patients on anti-tuberculosis therapy that can lead to permanent kidney damage. Rifampicin is the most offending drug. We report a case of a 41-years old man being treated for pulmonary tuberculosis and presenting with tubulointerstitial nephritis associated with rifampicin. We focus on diagnosis features and therapeutic challenges.